During these processes, proliferating CD34+SCs/TCs lose CD34 expression and gain αSMA expression, differentiating into myofibroblasts (cancer-associated fibroblasts, CAF, in tumors) [150,151,215]. This evidence concerns the gene CD34 and cancer.